Related Experiment Videos
Dexamethasone inhibition of the development of dysplastic bony lesions in LP/J mice
H A Brodie1, P S Chang, R A Chole
1Department of Otolaryngology-Head and Neck Surgery, University of California, School of Medicine, Davis.
Abstract:
Inbred LP/J mice have been observed to spontaneously develop abnormal bony lesions of the ossicles and otic capsule that progress throughout the life of the animals. This genetically inherited murine disorder produces bony lesions that share some gross and histologic features with bony lesions seen in human tympanosclerosis. Previous studies on LP/J mice have demonstrated evidence of immunologically mediated injury in the progression of the newly forming bony lesions. This study was designed to examine the effects of dexamethasone on the development of the bony lesions in LP/J mice. The purpose was to attempt to elucidate the relationship of the immunologic injury observed in earlier studies and the progression of the dysplastic bony lesions. The results show that LP/J mice treated with dexamethasone developed significantly fewer dysplastic bony lesions compared to the age-matched, saline-treated controls. There was also a statistically significant difference in the quantity and cellularity of the middle ear effusions between the experimental and control animals.
Insights
Dexamethasone treatment significantly reduced abnormal bony lesions in LP/J mice, suggesting a role for immunologic factors in this otic capsule disorder. This finding offers insights into potential therapeutic avenues for related human conditions.
Area of Science:
- Otolaryngology
- Immunology
- Genetics
- Pharmacology
Background:
- Inbred LP/J mice spontaneously develop progressive, abnormal bony lesions in the ossicles and otic capsule.
- These murine lesions share features with human tympanosclerosis and are associated with immunologically mediated injury.
- The precise relationship between immune response and lesion progression in this genetic disorder requires further elucidation.
Purpose of the Study:
- To investigate the therapeutic potential of dexamethasone in mitigating the development of spontaneous bony lesions in LP/J mice.
- To explore the role of immunologic injury in the progression of these dysplastic otic lesions by assessing dexamethasone's effects.
Main Methods:
- LP/J mice were treated with dexamethasone.
- Control groups received age-matched saline treatment.
- Development of bony lesions, middle ear effusion quantity, and cellularity were assessed and compared between groups.
Main Results:
- Dexamethasone-treated LP/J mice exhibited significantly fewer dysplastic bony lesions compared to saline-treated controls.
- A statistically significant difference in the quantity and cellularity of middle ear effusions was observed between dexamethasone and control groups.
- These findings suggest dexamethasone can inhibit the progression of spontaneous otic bony lesions in this murine model.
Conclusions:
- Dexamethasone administration effectively reduces the development of spontaneous bony lesions in LP/J mice.
- The results support the hypothesis that immunologic mechanisms contribute to the progression of these dysplastic otic lesions.
- This study highlights the potential of anti-inflammatory therapies in managing similar conditions characterized by bony proliferation and middle ear inflammation.